Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-23 Purchase | 2022-12-28 4:05 pm | Oncocyte Corp | OCX | Gutfreund John Peter Director | 75,000 | $0.3297 | $24,728 | 75,000 (Indirect) | View |
| 2022-08-15 Purchase | 2022-08-17 8:19 pm | Oncocyte Corp | OCX | Gutfreund John Peter Director | 25,000 | $0.93 | $23,250 | 80,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-30 Other | 2023-07-03 6:00 pm | N/A 2027-04-19 | Oncocyte Corp | OCX | Gutfreund John Peter Former Director Director | 6,649,775 | $0 | 7,941,914 (Indirect) | View |
| 2023-04-03 Option Award | 2023-04-05 9:30 pm | N/A N/A | Oncocyte Corp | OCX | Gutfreund John Peter Director | 1,705,000 | $0.3544 | 1,790,000 (Direct) | View |
| 2023-04-03 Disposition | 2023-04-05 9:30 pm | N/A 2024-04-08 | Oncocyte Corp | OCX | Gutfreund John Peter Director | 588 | $0 | 1,790,000 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 8:19 pm | N/A 2032-08-15 | Oncocyte Corp | OCX | Gutfreund John Peter Director | 55,000 | $0 | 80,000 (Direct) | View |
Ownership | 2022-08-08 4:28 pm | N/A N/A | Oncocyte Corp | OCX | Gutfreund John Peter Director | 0 | $0 | 6,650,951 (Indirect) | View |